(R)-2-Amino-2-(pyridin-4-yl)ethan-1-ol dihydrochloride, 95%, 100mg

1-(DIFLUOROMETHOXY)-3-FLUORO-2-METHYLBENZENE, 95.0%, 5g

3-Bromo-5-chloro-1,2,4-thiadiazole, 97.0%, 10g

Lenalidomide, 96.00%, 100g

3-(4-tert-butylphenyl)prop-2-ynoic acid, 95.0%, 2g

2-Methyl-1,2,5-thiadiazolidine 1,1-dioxide, 95.0%, 100mg

(3R,4R,5R)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol, 97.0%, 250mg

(1R,5R)-3-methyl-3,6-diazabicyclo[3.2.0]heptane; bis(trifluoroacetic acid), 95.0%, 5g

1-(4-Propylphenyl)-2,5-di(2-thienyl)-1H-pyrrole>98.0%(GC)200mg

Methyl 5-((phenylsulfonyl)methyl)furan-2-carboxylate, 95%, 2g

4-(4-Chloroquinazolin-7-yl)morpholine, 97%, 100mg

6-Bromo-2-fluoro-3-methylbenzaldehyde, 95.0%, 10g

3-Cyanoumbelliferone>98.0%(GC)1g